In this file
Comparing alternatives to Effecty is easier when you first identify what needs to change. A twelve-month equivalent is not the same financial proposition as a monthly renewal.
The provider’s current comparison point is: a lower monthly equivalent can require a longer supply purchase The entries below offer different care and payment arrangements to examine against that point.
How to use this shortlist
CoreAge Rx is listed first under a commercial partnership. The first position is predetermined by that relationship, and links may earn compensation. It is not an independent finding that CoreAge has the safest medicine, the lowest total price, or the strongest patient outcomes.
Use Effecty’s documented arrangement as the baseline, then test the alternatives against longer supply commitments and price equivalents. We compare public care descriptions and payment terms. We have not purchased treatment, audited every professional license, or timed the support response. Use the linked source notes and obtain a current personal quote.
01. CoreAge Rx · sponsored first position
This is the paid featured reference for the question in this guide. Its placement does not establish that every feature discussed here is available through its program. Ask about the exact product and care access before assuming a match.
CoreAge Rx provides an online route to medical assessment and, where a clinician prescribes, pharmacy fulfillment. The service is our paid featured partner. That commercial relationship buys its prominent position here; it does not establish a better medicine, a better outcome, or suitability for any particular reader.
The sale offer shows starting equivalents of $99 for semaglutide and $149 for tirzepatide, without a separate membership charge. Its billing explanation uses a three-month example: $149 per month becomes a single $447 payment. A reader should obtain the duration and total for the selected prescription rather than assuming that the smaller figure is charged monthly.
A question to put to the provider: Can you send the full payment schedule and the name of my dispensing pharmacy before I accept the offer?
Read the CoreAge Rx provider file and cost explanation for the connected details.
02. Joi + Blokes
The comparison point for Joi + Blokes: the quoted monthly amount is tied to quarterly billing
Joi + Blokes presents metabolic care alongside hormone and longevity services. Its GLP-1 page describes clinician consultations, medication support, and access to health coaches. Those roles should be explained separately so a patient knows which person answers a prescribing question and which provides coaching.
The GLP-1 page lists semaglutide at $179 per month with a $99 first-month offer, and tirzepatide at $249 per month with a $149 first-month offer. Both are labeled billed quarterly. Ask for the actual first invoice and renewal invoice; the smaller first-month number is not the entire quarterly commitment.
A question to put to the provider: What amount is collected for the first quarter, and how does cancellation affect medication already ordered for that period?
Read the Joi + Blokes provider file and its price and payment notes.
03. Mevo Health
The comparison point for Mevo Health: monthly, quarterly, and six-month terms need different commitment checks
Mevo Health describes an online medical consultation before treatment is recommended. Its public material focuses on compounded semaglutide and tirzepatide injections and ongoing provider support. A patient should ask how often assessment occurs and how concerns reach the clinician between routine renewals.
The page lists semaglutide from $199 and tirzepatide from $259. It also offers monthly, quarterly, and six-month plan lengths. Ask which term produces the displayed amount and how much is due at enrollment; an as-low-as figure is incomplete without its payment period.
A question to put to the provider: Which plan length produces my quoted price, and what financial obligation remains if the clinician changes treatment before that term ends?
Read the Mevo Health provider file and its price and payment notes.
04. Lttl
The comparison point for Lttl: the low starting offer and the pharmacy-processing cutoff answer different questions
Lttl groups its services into weight loss, longevity, and microdosing pathways. Its public page describes clinician review and online support. Marketing terms such as microdosing are not a standardized assurance of lower risk or greater suitability; the patient’s actual prescription needs its own assessment.
The homepage advertises weight-loss plans starting at $89 per month for semaglutide and $139 for tirzepatide, alongside first-month promotional messaging. Confirm the undiscounted renewal price, supply period, and complete invoice. A promotional minimum does not establish the amount every patient will pay.
A question to put to the provider: What will the next refill actually cost, and has my current order already crossed the pharmacy-processing cutoff?
Read the Lttl provider file and its price and payment notes.
05. Fifty 410
The comparison point for Fifty 410: Different package tiers mean a starter total is not the whole price story.
Fifty 410 describes online provider assessment and portal-based follow-up. The pricing material separates semaglutide purchased monthly from three-month tirzepatide packages and includes clinical review, medicine, and shipment in the listed packages.
The tirzepatide starter total is $399 for three months, with other listed tiers at $499 and $549. A monthly semaglutide option is $199. Match the quoted tier and treatment duration to the prescription before comparing those amounts.
A question to put to the provider: Does this package suit an existing patient, and what would the following package cost?
The Fifty 410 alternatives guide examines this arrangement in more detail. You can also consult the official provider page.
06. LumiMeds
The comparison point for LumiMeds: The starting semaglutide figure does not establish the entire payment term.
LumiMeds describes an online intake followed by clinical review, continuing check-ins, and pharmacy shipment where treatment is prescribed. It advertises no separate membership fee.
The refreshed homepage includes a compounded semaglutide starting figure of $89 with included-care language. It does not settle every product’s complete term and refill price. Obtain a current quote rather than carrying forward another treatment’s older advertised figure.
A question to put to the provider: How much is collected upfront, and what exact care and medication period does that payment cover?
Use the official LumiMeds page to request the current plan and conditions.
07. Elevate Health
The comparison point for Elevate Health: thirty-day and ninety-day offers need to be compared over the same period
Elevate Health describes clinician review, coaching, and a concierge-style program around medical weight management. Its current page names the TelegraMD network in the prescribing arrangement. Ask which benefits are ongoing services, which are promotional inclusions, and how a medication concern reaches the treating professional.
The reviewed tirzepatide offer shows $349 for the first period, followed by $449 per 30 days, or $897 for a 90-day supply. Those are different payment structures. A 90-day total should be considered alongside its upfront commitment, renewal terms, and the ability to change the clinical plan.
A question to put to the provider: Am I buying 30 days or 90 days, what amount will renew, and which care benefits remain included for that entire period?
Read the Elevate Health provider file and its price and payment notes.
Your starting point: Effecty
Effecty’s catalog separates compounded semaglutide and tirzepatide from branded products and other wellness treatments. It offers online clinical assessment and ongoing support. A product menu is not a personal treatment recommendation; the relevant comparison is the option the clinician proposes and the period being purchased.
The homepage lists semaglutide figures of $170, $150, and $130 per month and tirzepatide figures of $235, $210, and $190. Footnotes tie lower equivalents to three-month and twelve-month supply purchases. Confirm the full amount collected and how medication is dispensed across the term before comparing the smallest number.
What do I pay upfront for the advertised monthly equivalent, and what happens to the remaining commitment if treatment changes?
Make the decision concrete
Bring these three checks to the shortlist. If an answer describes another product, a different payment period, or a service you are not eligible for, the comparison is not finished.
- Record upfront payment, dispensing schedule, and unused-period terms.
- Request the named product, total initial payment, and next renewal in the same written quote.
- Confirm how the receiving clinician reviews existing treatment and how questions are handled between orders.
Separate the product from the provider
FDA approval belongs to a particular drug product, not to a review site’s list or a telehealth brand. A compounded preparation has not received that approval. Ingredient similarity does not establish the same route, formulation, manufacturing controls, or evidence.
Ask the clinician why the exact prescription fits your medical needs. Then ask the pharmacy for the label and instructions appropriate to that product. Read what compounding and FDA approval mean if those terms are being used interchangeably in a promotion.
Before accepting another offer
Keep the current agreement, prescription label, and any pending order information together. A new enrollment does not automatically stop the previous company’s next charge or authorize a continuation prescription.
Use the questions-before-purchase checklist to record the answers in your own words. A useful next step is a clear conversation and a complete proposal, not a decision based on a rank alone.
Source notes
Provider material describes the company’s own offer. Official medical references explain clinical and regulatory context; they do not endorse this publication or its commercial partner.
- CoreAge Rx: official treatment overview ↗Provider-published information · Checked September 22, 2026
- CoreAge Rx: current sale offer ↗Provider-published information · Checked September 22, 2026
- CoreAge Rx: plan billing explained ↗Provider-published information · Checked September 22, 2026
- CoreAge Rx: contact and professional-entity disclosures ↗Provider-published information · Checked September 22, 2026
- CoreAge Rx: purchasing process ↗Provider-published information · Checked September 22, 2026
- Joi+Blokes | Personalized Hormone & Wellness Care for Men & Women ↗Provider-published information · Checked September 22, 2026
- Compounded GLP-1 | Joi + Blokes ↗Provider-published information · Checked September 22, 2026
- Online GLP-1 Weight Loss | Board-Certified Physicians | Mevo Health ↗Provider-published information · Checked September 22, 2026
- FAQ: Treatment, Pricing & Shipping | Lttl ↗Provider-published information · Checked September 22, 2026
- Returns, Refunds, and Cancellation Policy | Lttl ↗Provider-published information · Checked September 22, 2026
- GLP-1 Weight Loss, Longevity & Microdosing | Lttl ↗Provider-published information · Checked September 22, 2026
- Fifty 410: official program, pricing, and care details ↗Provider-published information · Checked September 22, 2026
- LumiMeds: official program, pricing, and care details ↗Provider-published information · Checked September 22, 2026
- Elevate Health Rx, Medical Weight Loss, Built Around You ↗Provider-published information · Checked September 22, 2026
- Refund and Cancellation Policy - Elevate Health Rx ↗Provider-published information · Checked September 22, 2026
- Elevate Health Rx, Medical Weight Loss, Built Around You ↗Provider-published information · Checked September 22, 2026
- FAQ | Effecty ↗Provider-published information · Checked September 22, 2026
- Terms of Service | Effecty ↗Provider-published information · Checked September 22, 2026
- Effecty | Unveil your best self ↗Provider-published information · Checked September 22, 2026
- FDA: concerns with unapproved GLP-1 drugs ↗Regulatory / public agency · Checked September 22, 2026
- FDA: risks of compounded drugs ↗Regulatory / public agency · Checked September 22, 2026